statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO PR Newswire NEW YORK, April 10, 2024 NEW...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA...

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO

StockNews.com assumed coverage on shares of ARCA biopharma (NASDAQ:ABIO - Free Report) in a research note released on Thursday. The firm issued a sell rating on the biopharmaceutical company's stock...

ARCA biopharma (NASDAQ:ABIO) Earns Sell Rating from Analysts at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of ARCA biopharma (NASDAQ:ABIO - Get Free Report) in a note issued to investors on Thursday. The firm set a "sell" rating on the...

ARCA biopharma (NASDAQ:ABIO) Coverage Initiated at StockNews.com

NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, KTRA, ABIO

Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm PR Newswire NEW YORK, April 5, 2024 NEW YORK...

Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm

ARCA Biopharma stock drops on CEO departure...

ARCA Biopharma stock drops on CEO departure

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PIK, CHX, KTRA, ABIO SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PIK, CHX, KTRA, ABIO PR Newswire NEW YORK, April 4, 2024 NEW...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PIK, CHX, KTRA, ABIO

Merger to create a company focused on advancing Oruka's portfolio of novel biologics that aim to redefine the standard of care for patients with chronic skin diseases Oruka, the third company...

ARCA biopharma and Oruka Therapeutics Announce Merger Agreement

ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on the cardiovascular pathophysiology, molecular genetics, and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.

Volume	51,800.00
52-Wk High	$3.88
52-Wk Low	$1.56

ABIO ARCA biopharma Inc

About

Feed

News

Sentiment

Fundamentals